Related Experiment Video
Updated: Oct 26, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Acute Systemic Lupus Erythematous and Antiphospholipid Syndrome With Cardiac Complications
Manish Motwani1,2, Matthew Luckie1, Ben Parker3,4
1Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Acute systemic lupus erythematosus with antiphospholipid syndrome can cause serious cardiovascular issues. This case highlights the range of potential heart complications in patients with these conditions.
Area of Science:
- Rheumatology
- Cardiology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of blood clots.
- Cardiovascular complications are a significant cause of morbidity and mortality in SLE and APS.
Purpose of the Study:
- To illustrate the potential for multiple cardiovascular complications in a patient with acute systemic lupus erythematosus and antiphospholipid syndrome.
- To emphasize the importance of recognizing and managing cardiovascular risks in patients with concurrent SLE and APS.
Main Methods:
- Case report presentation.
- Review of clinical presentation, diagnostic workup, and management of a patient with acute SLE and APS.
Main Results:
- The case demonstrates a spectrum of cardiovascular complications arising from acute SLE with APS.
- Highlights the complex interplay between autoimmune activity and cardiovascular health.
Conclusions:
- Concurrent acute systemic lupus erythematosus and antiphospholipid syndrome pose a significant risk for diverse cardiovascular complications.
- Prompt diagnosis and comprehensive management are crucial for improving outcomes in these patients.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Rheumatic Heart Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction